PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

257 hedge funds and large institutions have $2.93B invested in Pacific Biosciences in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 86 increasing their positions, 60 reducing their positions, and 29 closing their positions.

Holders
257
Holders Change
+23
Holders Change %
+9.83%
% of All Funds
4.11%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
54
Increased
86
Reduced
60
Closed
29
Calls
$59.3M
Puts
$18.5M
Net Calls
+$40.8M
Net Calls Change
+$30.7M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.6M
2
APM
2
Avidity Partners Management
Texas
$44.1M
3
DTC
3
Deep Track Capital
Connecticut
$40.6M
4
FCM
4
Farallon Capital Management
California
$73.6M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$41.5M

Top Sellers

1
JSP
1
Jackson Square Partners
California
$140M
2
Capital International Investors
2
Capital International Investors
California
$48.8M
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$39.7M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$62.8M
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$1.71M
Name Holding Trade Value Shares
Change 		Shares
Change %
Parallax Volatility Advisers
276
Parallax Volatility Advisers
California
– -$8.12K -993 Closed
CS
277
Comerica Securities
Michigan
– -$6.09K -744 Closed
Fifth Third Bancorp
278
Fifth Third Bancorp
Ohio
– -$3.27K -400 Closed
PCM
279
Penserra Capital Management
California
– -$2K -310 Closed
RBC
280
Romano Brothers & Co
Illinois
– -$1.86K -227 Closed
BTI
281
Blue Trust Inc
Georgia
– -$1K -173 Closed
CWP
282
Concord Wealth Partners
Virginia
– -$188 -23 Closed
8 9 10 11
12